Hello,
We have the following scenario:
Our R&D team occasionally approaches the purchasing team and asks them to procure samples of raw materials.
If the sample yield positive results, they are integrated into our production processes (added to BOMs, procured, GI to prod. ord. etc).
When the purchasing team created the PO, they do not know which samples will eventually be used in the production process and which ones will be useles, so they do not initiate a new material creation process, but rather create a PO with AAC K and load the expanse on the R&D cost center. There is no need for inventory management at that point.
However, if a sample is going to be used in production, a new material must be created. The problem is with the valuation price of this materials: we use MAP for our ROH materials. We must update the MAP before we can create a production order (this is a strong business requirement - no production order if a component does not have a value, and value is only set through an initial GR against PO, MR21 is banned for this use).
But the initial GR against PO was already made, but not with the material, but rather with the K PO (as mentioned above). What we are forced to do - cancel the GR of the K PO, and do a GR against the same with a new line that contains the material we just created for the sample. That way, the new material gets a valuation price and then it can be produced.
Is there any other way to handle this kind of scenario? Should I just build a new material for every sample, regardless if it turns out to be useful or not?
Thanks.